X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE WOCKHARDT LTD. TTK HEALTHCARE/
WOCKHARDT LTD.
 
P/E (TTM) x 27.1 -11.6 - View Chart
P/BV x 6.0 2.3 258.0% View Chart
Dividend Yield % 0.5 1.4 34.2%  

Financials

 TTK HEALTHCARE   WOCKHARDT LTD.
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
WOCKHARDT LTD.
Mar-17
TTK HEALTHCARE/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs6631,129 58.8%   
Low Rs399627 63.6%   
Sales per share (Unadj.) Rs535.6363.1 147.5%  
Earnings per share (Unadj.) Rs15.9-20.4 -78.0%  
Cash flow per share (Unadj.) Rs20.0-7.0 -287.1%  
Dividends per share (Unadj.) Rs4.0010.00 40.0%  
Dividend yield (eoy) %0.81.1 66.1%  
Book value per share (Unadj.) Rs137.6301.8 45.6%  
Shares outstanding (eoy) m7.77110.55 7.0%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x1.02.4 41.0%   
Avg P/E ratio x33.3-42.9 -77.6%  
P/CF ratio (eoy) x26.5-125.9 -21.1%  
Price / Book Value ratio x3.92.9 132.7%  
Dividend payout %25.1-48.9 -51.3%   
Avg Mkt Cap Rs m4,12797,063 4.3%   
No. of employees `0001.76.8 25.2%   
Total wages/salary Rs m6079,665 6.3%   
Avg. sales/employee Rs Th2,436.75,931.8 41.1%   
Avg. wages/employee Rs Th355.21,428.1 24.9%   
Avg. net profit/employee Rs Th72.5-334.0 -21.7%   
INCOME DATA
Net Sales Rs m4,16240,146 10.4%  
Other income Rs m611,143 5.4%   
Total revenues Rs m4,22341,289 10.2%   
Gross profit Rs m197128 154.0%  
Depreciation Rs m321,489 2.1%   
Interest Rs m302,253 1.3%   
Profit before tax Rs m197-2,472 -8.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73-211 -34.5%   
Profit after tax Rs m124-2,260 -5.5%  
Gross profit margin %4.70.3 1,485.4%  
Effective tax rate %37.08.5 433.3%   
Net profit margin %3.0-5.6 -52.9%  
BALANCE SHEET DATA
Current assets Rs m1,62946,160 3.5%   
Current liabilities Rs m1,05819,258 5.5%   
Net working cap to sales %13.767.0 20.5%  
Current ratio x1.52.4 64.2%  
Inventory Days Days30101 29.6%  
Debtors Days Days3494 35.7%  
Net fixed assets Rs m55640,165 1.4%   
Share capital Rs m78553 14.1%   
"Free" reserves Rs m87832,814 2.7%   
Net worth Rs m1,06933,367 3.2%   
Long term debt Rs m15931,903 0.5%   
Total assets Rs m2,39989,687 2.7%  
Interest coverage x7.6-0.1 -7,802.7%   
Debt to equity ratio x0.11.0 15.5%  
Sales to assets ratio x1.70.4 387.5%   
Return on assets %6.40 -74,660.7%  
Return on equity %11.6-6.8 -171.0%  
Return on capital %18.5-0.3 -5,504.6%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m339,121 0.4%   
Fx outflow Rs m632,133 3.0%   
Net fx Rs m-306,988 -0.4%   
CASH FLOW
From Operations Rs m127-2,695 -4.7%  
From Investments Rs m-146-6,863 2.1%  
From Financial Activity Rs m2212,545 0.2%  
Net Cashflow Rs m33,010 0.1%  

Share Holding

Indian Promoters % 65.4 74.5 87.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 2.3 160.9%  
FIIs % 5.2 7.7 67.5%  
ADR/GDR % 0.0 0.1 -  
Free float % 25.8 15.4 167.5%  
Shareholders   12,723 67,757 18.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   PLETHICO PHARMA  BIOCON LTD  UNICHEM LAB  ALKEM LABORATORIES  AJANTA PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Oil Prices; RBI Minutes and Top Stocks in Action Today(Pre-Open)

Indian share markets surged on Wednesday, snapping a two-day losing streak led by gains Reliance Industries and bank stocks.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jun 20, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS